Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Artificial Intelligence and Healthcare
    • Consumer-Driven Health Care
      • Affordable Care Act
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Health Economics & Costs
      • Drug Prices & Regulations
      • Health Insurance
      • Health Reform
    • Medical Tourism
    • Telemedicine
    • Medicare
      • Single-Payer/Medicare-for-All
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Category: Drug Prices & Regulations

Why Don’t Some Promising Drugs Come to Market?

Posted on June 6, 2023June 5, 2023 by Devon Herrick

Earlier this year I wrote about bacteriophages, naturally-occurring antibiotics that are not widely available. Phases, as they’re called, are viruses found in nature that kill bacteria. Each is highly specific, killing only one kind of bacteria. That is (possibly) why pharmaceutical companies haven’t shown a lot of interest in developing them as antibiotic drug therapies. Drug companies would need to develop a different bacteriophage therapy for each pathogen targeted. Although mostly ignored by Western drug companies, phages were common in former Soviet-bloc countries. The following is an article about a rare, drug-resistant bacteria that affected Gulf War soldiers treatable only by phages.

+

Monday Links

Posted on June 5, 2023June 5, 2023 by John C. Goodman
  • Why the new food stamp work requirements matter.
  • Republicans have been as bad as Democrat’s when it comes to federal regulations.
  • How much do you like your job? 9 of 10 workers would give up a quarter of their lifetime earnings to do meaningful work. (WSJ)
  • Johns Hopkins study: less than 10% of Texas hospitals ever sued a patient for an unpaid bill. Even in those cases, the hospitals’ recovery was scanty and half the time the patients didn’t even show up at the hearing.
  • But here is an exception: A rich nonprofit hospital denies care to patients who don’t pay their bills. (NYT)
  • Noah Smith: there is a need for libertarianism after all. HT: Tyler
+

Saturday Links

Posted on June 3, 2023June 3, 2023 by John C. Goodman
  • Study: If the IRA drug price controls were in place in 2014, “between 24 and 49 therapies currently available today would most likely not have come to market and therefore not available for patients.” The act will cause patients to lose access to an estimated 40% of new medicines or up to 139 new therapies over the next decade.
  • Licensing laws are creating a shortage of dentists, just like they create a shortage of physicians.
  • AFP endorses the Pete Sessions health reform bill.
  • Study: School lunches no longer lead to more childhood obesity. But is that because the kids are throwing the food away?
+

Wednesday Links

Posted on May 31, 2023May 31, 2023 by John C. Goodman
  • The debt deal may actually weaken work requirements.  That’s because the bill’s new exemptions (for homeless people, veterans, and young adults who grew up in foster care) remove more people from existing work mandates than the number of people the bill adds.
  • In 2021, 42 million adults in the United States sought mental-health care of one form or another. But does therapy really work? The evidence is mixed. (NYT)
  • The Biden administration funds a grant to a project that discovers the GOP, Fox News, the Heritage Foundations, etc. are the foundation of Nazi, white supremacist and other hate groups.
  • “We find that a 1-year reduction in effective patent length reduces the number of new drugs brought to market from 46 to 39 per year (a 16% decline), decreasing in social welfare by $9.0 trillion between 2021 and 2050. Consumers incur 75.8% ($6.8 trillion) of the reduction in social welfare.”
+
  • Previous
  • 1
  • …
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • …
  • 188
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 36 other subscribers

Popular Topics

©2025 The Goodman Institute Health Blog | Website by Lexicom